Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Suppression of basophil histamine release and other IgE-dependent responses in childhood Schistosoma mansoni/hookworm coinfection.

Pinot de Moira A, Fitzsimmons CM, Jones FM, Wilson S, Cahen P, Tukahebwa E, Mpairwe H, Mwatha JK, Bethony JM, Skov PS, Kabatereine NB, Dunne DW.

J Infect Dis. 2014 Oct 15;210(8):1198-206. doi: 10.1093/infdis/jiu234. Epub 2014 Apr 29.

2.

Aflatoxin exposure is inversely associated with IGF1 and IGFBP3 levels in vitro and in Kenyan schoolchildren.

Castelino JM, Routledge MN, Wilson S, Dunne DW, Mwatha JK, Gachuhi K, Wild CP, Gong YY.

Mol Nutr Food Res. 2015 Mar;59(3):574-81. doi: 10.1002/mnfr.201300619. Epub 2014 Jan 25.

3.

Posttreatment changes in cytokines induced by Schistosoma mansoni egg and worm antigens: dissociation of immunity- and morbidity-associated type 2 responses.

Wilson S, Jones FM, Kenty LC, Mwatha JK, Kimani G, Kariuki HC, Dunne DW.

J Infect Dis. 2014 Jun 1;209(11):1792-800. doi: 10.1093/infdis/jit826. Epub 2013 Dec 19.

4.

Long term study on the effect of mollusciciding with niclosamide in stream habitats on the transmission of schistosomiasis mansoni after community-based chemotherapy in Makueni District, Kenya.

Kariuki HC, Madsen H, Ouma JH, Butterworth AE, Dunne DW, Booth M, Kimani G, Mwatha JK, Muchiri E, Vennervald BJ.

Parasit Vectors. 2013 Apr 18;6:107. doi: 10.1186/1756-3305-6-107.

5.

Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.

Wilson S, Jones FM, Fofana HK, Doucouré A, Landouré A, Kimani G, Mwatha JK, Sacko M, Vennervald BJ, Dunne DW.

PLoS Negl Trop Dis. 2013;7(3):e2149. doi: 10.1371/journal.pntd.0002149. Epub 2013 Mar 28.

6.

A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.

Wilson S, Jones FM, Fofana HK, Landouré A, Kimani G, Mwatha JK, Sacko M, Vennervald BJ, Dunne DW.

Parasite Immunol. 2013 Jul;35(7-8):224-8. doi: 10.1111/pim.12035.

7.

Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections.

Pinot de Moira A, Jones FM, Wilson S, Tukahebwa E, Fitzsimmons CM, Mwatha JK, Bethony JM, Kabatereine NB, Dunne DW.

Infect Immun. 2013 Jan;81(1):23-32. doi: 10.1128/IAI.00748-12. Epub 2012 Oct 15.

8.

B-cell activity in children with malaria.

Korir JC, Magambo JK, Mwatha JK, Waitumbi JN.

Malar J. 2012 Mar 9;11:66. doi: 10.1186/1475-2875-11-66.

9.

Aflatoxin exposure may contribute to chronic hepatomegaly in Kenyan school children.

Gong YY, Wilson S, Mwatha JK, Routledge MN, Castelino JM, Zhao B, Kimani G, Kariuki HC, Vennervald BJ, Dunne DW, Wild CP.

Environ Health Perspect. 2012 Jun;120(6):893-6. doi: 10.1289/ehp.1104357. Epub 2012 Feb 27.

10.

Locating irregularly shaped clusters of infection intensity.

Yiannakoulias N, Wilson S, Kariuki HC, Mwatha JK, Ouma JH, Muchiri E, Kimani G, Vennervald BJ, Dunne DW.

Geospat Health. 2010 May;4(2):191-200.

PMID:
20503188
11.

Intestinal polyparasitism in a rural Kenyan community.

Nguhiu PN, Kariuki HC, Magambo JK, Kimani G, Mwatha JK, Muchiri E, Dunne DW, Vennervald BJ, Mkoji GM.

East Afr Med J. 2009 Jun;86(6):272-8.

PMID:
20358789
12.

Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoni.

Wilson S, Vennervald BJ, Kadzo H, Ireri E, Amaganga C, Booth M, Kariuki HC, Mwatha JK, Kimani G, Ouma JH, Muchiri E, Dunne DW.

Trans R Soc Trop Med Hyg. 2010 Feb;104(2):110-6. doi: 10.1016/j.trstmh.2009.08.006. Epub 2009 Oct 8.

13.

Hepatosplenomegaly associated with chronic malaria exposure: evidence for a pro-inflammatory mechanism exacerbated by schistosomiasis.

Wilson S, Jones FM, Mwatha JK, Kimani G, Booth M, Kariuki HC, Vennervald BJ, Ouma JH, Muchiri E, Dunne DW.

Parasite Immunol. 2009 Feb;31(2):64-71. doi: 10.1111/j.1365-3024.2008.01078.x.

14.

Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection.

Wilson S, Jones FM, Mwatha JK, Kimani G, Booth M, Kariuki HC, Vennervald BJ, Ouma JH, Muchiri E, Dunne DW.

Infect Immun. 2008 May;76(5):2212-8. doi: 10.1128/IAI.01433-07. Epub 2008 Feb 19.

15.

Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection.

Wilson S, Vennervald BJ, Kadzo H, Ireri E, Amaganga C, Booth M, Kariuki HC, Mwatha JK, Kimani G, Ouma JH, Muchiri E, Dunne DW.

Trop Med Int Health. 2007 Dec;12(12):1442-9.

16.

Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection.

Wilson S, Booth M, Jones FM, Mwatha JK, Kimani G, Kariuki HC, Vennervald BJ, Ouma JH, Muchiri E, Dunne DW.

BMC Infect Dis. 2007 Jun 29;7:67.

17.

Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure.

Fitzsimmons CM, McBeath R, Joseph S, Jones FM, Walter K, Hoffmann KF, Kariuki HC, Mwatha JK, Kimani G, Kabatereine NB, Vennervald BJ, Ouma JH, Dunne DW.

Int Arch Allergy Immunol. 2007;142(1):40-50. Epub 2006 Oct 2.

PMID:
17019080
18.

Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens.

Walter K, Fulford AJ, McBeath R, Joseph S, Jones FM, Kariuki HC, Mwatha JK, Kimani G, Kabatereine NB, Vennervald BJ, Ouma JH, Dunne DW.

J Immunol. 2006 Oct 15;177(8):5490-8.

19.

Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levels.

Booth M, Shaw MA, Carpenter D, Joseph S, Kabatereine NB, Kariuki HC, Mwatha JK, Jones FM, Vennervald BJ, Ouma JH, Dunne DW.

J Immunol. 2006 Jun 1;176(11):7112-8.

20.

Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Reimert CM, Fitzsimmons CM, Joseph S, Mwatha JK, Jones FM, Kimani G, Hoffmann KF, Booth M, Kabatereine NB, Dunne DW, Vennervald BJ.

Clin Vaccine Immunol. 2006 May;13(5):584-93.

21.

Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, Uganda.

Dunne DW, Vennervald BJ, Booth M, Joseph S, Fitzsimmons CM, Cahen P, Sturrock RF, Ouma JH, Mwatha JK, Kimani G, Kariuki HC, Kazibwe F, Tukahebwa E, Kabatereine NB.

Trans R Soc Trop Med Hyg. 2006 Mar;100(3):216-23. Epub 2005 Dec 15.

PMID:
16359714
22.

Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children.

Booth M, Vennervald BJ, Butterworth AE, Kariuki HC, Amaganga C, Kimani G, Mwatha JK, Otedo A, Ouma JH, Dunne DW.

BMC Med. 2004 Sep 27;2:36.

23.

Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel.

Joseph S, Jones FM, Walter K, Fulford AJ, Kimani G, Mwatha JK, Kamau T, Kariuki HC, Kazibwe F, Tukahebwa E, Kabatereine NB, Ouma JH, Vennervald BJ, Dunne DW.

J Infect Dis. 2004 Aug 15;190(4):835-42. Epub 2004 Jul 12.

PMID:
15272413
24.

Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.

Fitzsimmons CM, Joseph S, Jones FM, Reimert CM, Hoffmann KF, Kazibwe F, Kimani G, Mwatha JK, Ouma JH, Tukahebwa EM, Kariuki HC, Vennervald BJ, Kabatereine NB, Dunne DW.

Infect Immun. 2004 Jul;72(7):4023-30.

25.

Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children.

Booth M, Vennervald BJ, Kenty L, Butterworth AE, Kariuki HC, Kadzo H, Ireri E, Amaganga C, Kimani G, Mwatha JK, Otedo A, Ouma JH, Muchiri E, Dunne DW.

BMC Infect Dis. 2004 May 17;4:13.

26.

Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.

Satti MZ, Cahen P, Skov PS, Joseph S, Jones FM, Fitzsimmons C, Hoffmann KF, Reimert C, Kariuki HC, Kazibwe F, Mwatha JK, Kimani G, Vennervald BJ, Ouma JH, Kabatereine NB, Dunne DW.

BMC Immunol. 2004 Apr 21;5:6.

27.

Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence.

Booth M, Vennervald BJ, Kabatereine NB, Kazibwe F, Ouma JH, Kariuki CH, Muchiri E, Kadzo H, Ireri E, Kimani G, Mwatha JK, Dunne DW.

Trans R Soc Trop Med Hyg. 2004 Feb;98(2):125-36.

PMID:
14964813
28.

Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens.

Joseph S, Jones FM, Kimani G, Mwatha JK, Kamau T, Kazibwe F, Kemijumbi J, Kabatereine NB, Booth M, Kariuki HC, Ouma JH, Vennervald BJ, Dunne DW.

Infect Immun. 2004 Feb;72(2):728-34.

29.

Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender.

Booth M, Mwatha JK, Joseph S, Jones FM, Kadzo H, Ireri E, Kazibwe F, Kemijumbi J, Kariuki C, Kimani G, Ouma JH, Kabatereine NB, Vennervald BJ, Dunne DW.

J Immunol. 2004 Jan 15;172(2):1295-303.

30.

IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis.

Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, Vennervald BJ, Ouma JH, Mwatha JK, Jones FM, Donaldson DD, Grusby MJ, Dunne DW, Wynn TA.

Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):586-90. Epub 2003 Dec 29.

31.

Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren.

Mwatha JK, Jones FM, Mohamed G, Naus CW, Riley EM, Butterworth AE, Kimani G, Kariuki CH, Ouma JH, Koech D, Dunne DW.

J Infect Dis. 2003 Apr 15;187(8):1337-41. Epub 2003 Apr 2.

PMID:
12696017
32.

Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum.

Naus CW, Jones FM, Satti MZ, Joseph S, Riley EM, Kimani G, Mwatha JK, Kariuki CH, Ouma JH, Kabatereine NB, Vennervald BJ, Dunne DW.

J Infect Dis. 2003 Apr 15;187(8):1272-82. Epub 2003 Apr 2.

PMID:
12696007
33.

High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.

Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, Mumo J, Fulford AJ, Jones FM, Butterworth AE, Roberts MB, Dunne DW.

J Immunol. 1998 Feb 15;160(4):1992-9.

Supplemental Content

Loading ...
Support Center